| Anti-melanoma differentiation–associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features DJB Kurtzman, RA Vleugels Journal of the American Academy of Dermatology 78 (4), 776-785, 2018 | 202 | 2018 |
| Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade SS Ali, AL Goddard, JJ Luke, H Donahue, DJ Todd, A Werchniak, ... JAMA dermatology 151 (2), 195-199, 2015 | 166 | 2015 |
| Calciphylaxis: a systematic review of existing and emerging therapies C Vedvyas, LS Winterfield, RA Vleugels Journal of the American Academy of Dermatology 67 (6), e253-e260, 2012 | 148 | 2012 |
| Tofacitinib citrate for refractory cutaneous dermatomyositis: an alternative treatment DJB Kurtzman, NA Wright, J Lin, AN Femia, JF Merola, M Patel, ... JAMA dermatology 152 (8), 944-945, 2016 | 141 | 2016 |
| Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis C Huard, SV Gullà, DV Bennett, AJ Coyle, RA Vleugels, SA Greenberg British Journal of Dermatology 176 (5), 1224-1230, 2017 | 115 | 2017 |
| A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies AGS Oldroyd, AB Allard, JP Callen, H Chinoy, L Chung, D Fiorentino, ... Rheumatology 60 (6), 2615-2628, 2021 | 114 | 2021 |
| Mitochondrial DNA deletions serve as biomarkers of aging in the skin, but are typically absent in nonmelanoma skin cancers A Eshaghian, RA Vleugels, JA Canter, MA McDonald, T Stasko, JE Sligh Journal of investigative dermatology 126 (2), 336-344, 2006 | 114 | 2006 |
| Dermatomyositis: an update on diagnosis and treatment GA Cobos, A Femia, RA Vleugels American Journal of Clinical Dermatology 21 (3), 339-353, 2020 | 97 | 2020 |
| A population-based study of acne and body mass index in adolescents JA Halvorsen, RA Vleugels, E Bjertness, L Lien Archives of dermatology 148 (1), 131-132, 2012 | 94 | 2012 |
| Psoriatic alopecia/alopecia areata–like reactions secondary to anti–tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia LA Doyle, LC Sperling, S Baksh, J Lackey, B Thomas, RA Vleugels, ... The American journal of dermatopathology 33 (2), 161-166, 2011 | 92 | 2011 |
| Eosinophilic fasciitis: an updated review on diagnosis and treatment DR Mazori, AN Femia, RA Vleugels Current rheumatology reports 19, 1-12, 2017 | 91 | 2017 |
| Safety of systemic agents for the treatment of pediatric psoriasis IMGJ Bronckers, MMB Seyger, DP West, I Lara-Corrales, M Tollefson, ... JAMA dermatology 153 (11), 1147-1157, 2017 | 91 | 2017 |
| Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers NA Wright, DR Mazori, M Patel, JF Merola, AN Femia, RA Vleugels JAMA dermatology 152 (1), 97-99, 2016 | 82 | 2016 |
| Cutaneous dermatomyositis: an updated review of treatment options and internal associations AN Femia, RA Vleugels, JP Callen American journal of clinical dermatology 14, 291-313, 2013 | 78 | 2013 |
| Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women S Wu, J Han, RA Vleugels, R Puett, F Laden, DJ Hunter, AA Qureshi British journal of cancer 110 (7), 1855-1861, 2014 | 77 | 2014 |
| Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies AC Laga, RA Vleugels, AA Qureshi, EF Velazquez The American journal of dermatopathology 32 (6), 568-573, 2010 | 77 | 2010 |
| A multicenter cross-sectional study and systematic review of necrobiotic xanthogranuloma with proposed diagnostic criteria CA Nelson, CS Zhong, DA Hashemi, HJ Ashchyan, Z Brown-Joel, ... JAMA dermatology 156 (3), 270-279, 2020 | 63 | 2020 |
| Treatment options for pityriasis rubra pilaris including biologic agents: a retrospective analysis from an academic medical center AB Eastham, AN Femia, A Qureshi, RA Vleugels JAMA dermatology 150 (1), 92-94, 2014 | 62 | 2014 |
| Clinical features and comorbidities of patients with necrobiosis lipoidica with or without diabetes DA Hashemi, ZO Brown-Joel, E Tkachenko, CA Nelson, MH Noe, ... JAMA dermatology 155 (4), 455-459, 2019 | 55 | 2019 |
| Dermatomyositis induced by anti–tumor necrosis factor in a patient with juvenile idiopathic arthritis SW Liu, NF Velez, C Lam, A Femia, SR Granter, HB Townsend, ... JAMA dermatology 149 (10), 1204-1208, 2013 | 55 | 2013 |
